Health aid displacement during a decade of conflict (2011-19) in Syria: an exploratory analysis.
Conflict
Development
Fungibility
Health aid
Health aid displacement
Humanitarian aid
IDPs
Syrian crisis
Journal
BMC public health
ISSN: 1471-2458
Titre abrégé: BMC Public Health
Pays: England
ID NLM: 100968562
Informations de publication
Date de publication:
17 08 2023
17 08 2023
Historique:
received:
20
02
2023
accepted:
31
07
2023
medline:
18
8
2023
pubmed:
17
8
2023
entrez:
16
8
2023
Statut:
epublish
Résumé
Syria has been in continuous conflict since 2011, resulting in more than 874,000 deaths and 13.7 million internally displaced people (IDPs) and refugees. The health and humanitarian sectors have been severely affected by the protracted, complex conflict and have relied heavily on donor aid in the last decade. This study examines the extent and implications of health aid displacement in Syria during acute humanitarian health crises from 2011 to 2019. We conducted a trend analysis on data related to humanitarian and health aid for Syria between 2011 and 2019 from the OECD's Creditor Reporting System. We linked the data obtained for health aid displacement to four key dimensions of the Syrian conflict. The data were compared with other fragile states. We conducted a workshop in Turkey and key informants with experts, policy makers and aid practitioners involved in the humanitarian and health response in Syria between August and October 2021 to corroborate the quantitative data obtained by analysing aid repository data. The findings suggest that there was health aid displacement in Syria during key periods of crisis by a few key donors, such as the EU, Germany, Norway and Canada supporting responses to certain humanitarian crises. However, considering that the value of humanitarian aid is 50 times that of health aid, this displacement cannot be considered as critical. Also, there was insufficient evidence of health displacement across all donors. The results also showed that the value of health aid as a proportion of aggregate health and humanitarian aid is only 2% in Syria, compared to 22% for the combined average of fragile states, which further indicates the predominance of humanitarian aid over health aid in the Syrian crisis context. This study highlights that in very complex conflict-affected contexts such as Syria, it is difficult to suggest the use of health aid displacement as an effective tool for aid-effectiveness for donors as it does not reflect domestic needs and priorities. Yet there seems to be evidence of slight displacement for individual donors. However, we can suggest that donors vastly prefer to focus their investment in the humanitarian sector rather than the health sector in conflict-affected areas. There is an urgent need to increase donors' focus on Syria's health development aid and adopt the humanitarian-development-peace nexus to improve aid effectiveness that aligns with the increasing health needs of local communities, including IDPs, in this protracted conflict.
Sections du résumé
BACKGROUND
Syria has been in continuous conflict since 2011, resulting in more than 874,000 deaths and 13.7 million internally displaced people (IDPs) and refugees. The health and humanitarian sectors have been severely affected by the protracted, complex conflict and have relied heavily on donor aid in the last decade. This study examines the extent and implications of health aid displacement in Syria during acute humanitarian health crises from 2011 to 2019.
METHODS
We conducted a trend analysis on data related to humanitarian and health aid for Syria between 2011 and 2019 from the OECD's Creditor Reporting System. We linked the data obtained for health aid displacement to four key dimensions of the Syrian conflict. The data were compared with other fragile states. We conducted a workshop in Turkey and key informants with experts, policy makers and aid practitioners involved in the humanitarian and health response in Syria between August and October 2021 to corroborate the quantitative data obtained by analysing aid repository data.
RESULTS
The findings suggest that there was health aid displacement in Syria during key periods of crisis by a few key donors, such as the EU, Germany, Norway and Canada supporting responses to certain humanitarian crises. However, considering that the value of humanitarian aid is 50 times that of health aid, this displacement cannot be considered as critical. Also, there was insufficient evidence of health displacement across all donors. The results also showed that the value of health aid as a proportion of aggregate health and humanitarian aid is only 2% in Syria, compared to 22% for the combined average of fragile states, which further indicates the predominance of humanitarian aid over health aid in the Syrian crisis context.
CONCLUSION
This study highlights that in very complex conflict-affected contexts such as Syria, it is difficult to suggest the use of health aid displacement as an effective tool for aid-effectiveness for donors as it does not reflect domestic needs and priorities. Yet there seems to be evidence of slight displacement for individual donors. However, we can suggest that donors vastly prefer to focus their investment in the humanitarian sector rather than the health sector in conflict-affected areas. There is an urgent need to increase donors' focus on Syria's health development aid and adopt the humanitarian-development-peace nexus to improve aid effectiveness that aligns with the increasing health needs of local communities, including IDPs, in this protracted conflict.
Identifiants
pubmed: 37587403
doi: 10.1186/s12889-023-16428-7
pii: 10.1186/s12889-023-16428-7
pmc: PMC10433618
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1562Subventions
Organisme : Department of Health
Pays : United Kingdom
Informations de copyright
© 2023. BioMed Central Ltd., part of Springer Nature.
Références
PLOS Glob Public Health. 2023 Apr 11;3(4):e0001340
pubmed: 37040334
Health Res Policy Syst. 2023 Aug 30;21(1):88
pubmed: 37649119
Lancet Glob Health. 2020 Nov;8(11):e1369
pubmed: 33007214
Int J Health Policy Manag. 2019 Jan 09;8(4):233-244
pubmed: 31050968
PLoS Curr. 2014 May;6:
pubmed: 24894417
BMJ. 2020 Feb 6;368:m451
pubmed: 32029428
Confl Health. 2022 Nov 9;16(1):57
pubmed: 36352438
BMJ Glob Health. 2021 Jun;6(6):
pubmed: 34108147
Lancet. 2010 Apr 17;375(9723):1375-87
pubmed: 20381856
Lancet Glob Health. 2023 May;11(5):e653-e654
pubmed: 36913958
BMJ Glob Health. 2022 May;7(5):
pubmed: 35589154
BMJ Glob Health. 2019 Oct 08;4(5):e001513
pubmed: 31646007
Health Policy. 2011 May;100(2-3):116-24
pubmed: 20828855
Soc Sci Med. 2016 Jun;159:161-9
pubmed: 27183131
Lancet Glob Health. 2020 Mar;8(3):e374-e386
pubmed: 32035034
Disaster Med Public Health Prep. 2018 Oct;12(5):567-568
pubmed: 29350611